13F Holdings
中文EN

ALC ALCON INC IFRS

Ophthalmic Goods · NYSE · SEC CIK 1167379 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY4.9%
TTM net income YoY-3.7%
TTM EPS YoY-3.4%
Revenue 3-yr CAGR6.1%
Net income 3-yr CAGR43.0%

Margins

Gross margin55.2%
Operating margin13.1%
Net margin9.4%
FCF margin16.6%
EBITDA margin—

Returns

ROE4.5%
ROA3.2%
ROIC (approx.)4.6%
Asset turnover0.34x

Leverage & solvency

Liabilities / assets30.2%
Debt / equity0.21x
Current ratio2.12x
Interest coverage6.67x

Cash quality & payout

Operating cash flow / net income2.32x
Accruals ratio-4.2%
Payout ratio16.9%
Capex / revenue5.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2025Q22025-06-302024Q22024-06-302023Q2*2023-06-302022Q2*2022-06-302021Q2*2021-06-302020Q2*2020-06-302019Q2*2019-06-302018Q2*2018-06-30
Income statement
Revenue$2.60B$2.50B$2.42B$2.22B$2.11B$1.21B$1.90B$1.82B
Cost of revenue$1.20B$1.11B$1.04B$999.00M$875.00M$854.00M$922.00M$942.00M
Gross profit$1.39B$1.37B$1.36B$1.20B$1.22B$345.00M$947.00M$878.00M
R&D expense$245.00M$220.00M$217.00M$181.00M$178.00M$163.00M$167.00M$152.00M
SG&A expense$870.00M$837.00M$832.00M$803.00M$785.00M$595.00M$760.00M$722.00M
Operating income$247.00M$318.00M$270.00M$200.00M$229.00M-$466.00M-$53.00M$38.00M
Interest expense$51.00M$50.00M$48.00M$31.00M$30.00M$30.00M$35.00M$6.00M
Pretax income$199.00M$280.00M$213.00M$147.00M$191.00M-$502.00M-$96.00M$24.00M
Income tax$23.00M$57.00M$44.00M-$1.00M$40.00M-$80.00M$294.00M$9.00M
Net income$176.00M$223.00M$169.00M$148.00M$151.00M-$422.00M-$390.00M$15.00M
EPS (basic)0.360.450.340.300.31-0.86-0.800.03
EPS (diluted)0.350.450.340.300.31-0.86-0.800.03
Weighted avg. shares (diluted)497.90M497.00M495.70M494.30M493.20M489.00M488.20M488.20M
Balance sheet
Cash & equivalents$1.41B$1.37B$661.00M$1.03B$1.37B$1.32B$721.00M$151.00M
Short-term investments$0———————
Receivables$1.99B$1.83B$1.79B$1.60B$1.46B$1.17B$1.41B—
Inventory$2.39B$2.33B$2.27B$1.99B$1.80B$1.66B$1.49B—
Current assets$6.31B$5.99B$5.20B$5.02B$5.02B$4.63B$4.14B—
PP&E, netmay include right-of-use assets (IFRS)$4.61B$4.33B$4.09B$3.74B$3.44B$3.14B$2.89B—
Goodwill$9.18B$8.93B$8.97B$8.90B$8.90B$8.90B$8.90B—
Intangibles$9.20B$8.76B$9.37B$8.81B$9.19B$9.69B$10.72B—
Total assets$31.39B$29.72B$29.21B$27.73B$27.75B$27.48B$27.77B—
Current liabilities$2.42B$2.34B$2.41B$2.32B$2.20B$2.08B$3.82B—
Short-term debt$81.00M$137.00M$100.00M$87.00M$136.00M$235.00M$1.77B—
Long-term debt$4.66B$4.55B$4.58B$3.88B$3.99B$3.91B$1.75B—
Total debt$4.75B$4.69B$4.68B$3.97B$4.12B$4.14B$3.52B—
Total liabilities$9.26B$8.78B$9.27B$8.19B$8.69B$8.71B$8.32B—
Shareholders' equity$22.11B$20.94B$19.94B$19.54B$19.06B$18.77B$19.45B$22.73B
Net debt$3.34B$3.31B$4.02B$2.94B$2.76B$2.82B$2.80B—
Shares outstanding494.40M494.50M493.10M491.60M490.00M489.10M——
Cash flow statement
Operating cash flow————————

Free plan shows the latest 8 periods; Pro shows all 19 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.